The ATG9A gene helps cells carry out autophagy, a built in cleanup process that recycles worn out parts and supports healthy brain development. If this gene does not work properly, cells may struggle to clear and reuse material, which can affect how the brain and nervous system develop and function. People with two nonworking ATG9A variants can have developmental delay, low muscle tone, movement or balance problems, and differences in brain growth.
What is a gene?
Genes are segments of DNA that carry instructions cells use to make molecules or direct processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do the work. Others mainly help regulate when certain processes occur, where they occur, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to read more about this topic, you can find additional information in the LearnHub.
Overview
ATG9AGene function
What if the gene works
The ATG9A gene helps cells recycle worn out parts through autophagy, the cell’s cleanup process. This supports cell health, especially in the brain, by helping manage stress and maintain energy balance.
Risk
What if the gene does not work
More disruptive variants in the ATG9A gene can impair brain development and movement, causing a rare neurodevelopmental condition with developmental delay, intellectual disability, and low muscle tone. Milder variants may lead to later onset or less marked features.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the ATG9A gene, no ATG9A-specific treatment or management approach is currently established.
Gene function
What if the gene works
Inside your cells, the ATG9A gene supports the steady cleanup and recycling system that keeps cell contents in good working order. Understanding how the ATG9A gene helps cells recycle worn out parts makes it easier to see how cells stay balanced over time. When this gene is working as expected, cells can gather, move, and reuse materials in a controlled way.
The ATG9A gene helps your cells build the membrane sacs used in autophagy (the cell's recycling system). These sacs collect older or unneeded cell material so it can be broken down and reused.
Its protein moves membrane material between cell compartments and delivers it to the growing recycling sac. This steady flow helps the process start and expand in a controlled way.
By supporting autophagy, the ATG9A gene helps cells turn worn out proteins and cell parts into raw materials they can use again. This helps cells meet everyday energy and maintenance needs.
The ATG9A gene supports routine cell housekeeping, especially when cells need to adjust to short periods of low nutrient supply. This helps cells keep their contents organized and balanced.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ATG9A gene can alter the ATG9A protein’s shape, stability, or movement inside cells, which may disrupt the membrane trafficking needed for autophagy, the cell’s recycling system. Research on how variants in the ATG9A gene affect cells shows a spectrum, from milder changes that leave some activity to more severe variants that greatly reduce or abolish function. In people with ATG9A-related conditions, this difference can influence when features appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the ATG9A gene cause a rare neurodevelopmental condition that may include developmental delay, intellectual disability, low muscle tone, movement or balance problems, and differences seen on brain scans. Research on ATG9A gene variants and related health conditions is still growing, and the exact pattern can vary from person to person, but this diagnosis is linked to rare disease causing variants rather than common DNA differences.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ATG9A gene. In families with an ATG9A-related condition, risk is mainly tied to the genetic change itself, and a doctor or genetic counselor can help explain what that means for you or your family.
Inheritance of ATG9A variants
ATG9A-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one ATG9A gene variant from each parent, and the parents are typically healthy carriers. When both parents carry an ATG9A gene variant, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of a child being a carrier, and a 25% chance of a child inheriting neither variant. In families asking how ATG9A gene variants are inherited, this pattern means the condition can affect brothers and sisters even when neither parent has symptoms.
What does my ATG9A result mean for my family?
For families with an ATG9A-related condition, the pattern is usually recessive. This often means parents are healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition. Other relatives on both sides of the family may carry the same gene change, especially if there is a family history of similar symptoms.
Genetic information
Genetic testing
How you find out about variants
Variants in the ATG9A gene are usually found with genetic testing for ATG9A variants using a blood sample or saliva sample. A lab reads the DNA sequence and checks for changes, often as part of a multigene panel, exome sequencing, or whole genome sequencing. Results can show whether a variant is present.
When should I consider getting a genetic test?
Genetic testing for the ATG9A gene may be worth considering when a child has unexplained developmental delay, low muscle tone or muscle stiffness, trouble with movement, or a smaller-than-expected head size. It can also help when there is a known ATG9A variant in the family or more than one affected child.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and the kind of variant involved. Factors such as age, lifestyle, environment, and medical history also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood as part of the broader picture of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may process a drug more slowly or more quickly than another, which can change how strongly it works or how likely side effects are. These differences are common and help explain why the same treatment may feel very effective for some people, less helpful for others, or lead to greater sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene drug patterns to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the ATG9A gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in medication response at this time, so questions about side effects, new symptoms, or changes in your medicines are best discussed with your doctor or pharmacist.
History
ATG9A emerged from the broader story of autophagy research, a field that grew rapidly after key autophagy genes were identified in yeast in the 1990s. In recent decades, awareness of this gene’s role has grown as scientists linked the yeast findings to similar genes in humans. Human ATG9A became part of that next wave of discovery when researchers recognized it as the main human version of ATG9. Building on this early work, scientists uncovered more about the gene through cell studies that helped map the machinery involved in autophagy. Interest in ATG9A increased further as genetic studies connected rare variants in the gene with human neurodevelopmental conditions. These historical steps shaped today’s understanding of ATG9A as part of an important pathway first uncovered through basic science.